Clinical Trial Update: Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture [Phase 4]

View source ↗

Summary

Pfizer-sponsored Phase 4 trial investigating tranexamic acid to reduce blood loss during surgery for femoral fractures. The trial results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoral Fracture

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Pfizer | Conditions: Femoral Fractures | Phase 4 | Status: COMPLETED | Results posted: 2011-06-28